Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | BLM | P54132 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | PLG | P00747 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 6/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 6/20 | 0.41 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.41 |
| ▸ | GABRP | O00591 | 1/20 | 0.41 |
| ▸ | GABRD | O14764 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21989009 | 0.86 | ALDH1A1 (0.41) | NFKB1CYP2D6LMNAALDH1A1KMT2A | |
| SCHEMBL157395 | 0.78 | ALDH1A1 (0.48) | NFKB1LMNAALDH1A1KMT2AMEN1 | |
| SCHEMBL986920 | 0.76 | ALDH1A1 (0.52) | NFKB1LMNAALDH1A1KMT2AMEN1 | |
| SCHEMBL21560981 | 0.74 | LMNA (0.44) | NFKB1LMNAALDH1A1KMT2AMEN1 | |
| SCHEMBL19333419 | 0.73 | TSHR (0.46) | NFKB1LMNAALDH1A1KMT2AMEN1 | |
| SCHEMBL13531550 | 0.73 | ABCC4 (0.40) | NFKB1CYP2D6LMNAALDH1A1KMT2A | |
| SCHEMBL348477 | 0.73 | LMNA (0.52) | NFKB1CYP2D6LMNAALDH1A1KMT2A | |
| SCHEMBL29065914 | 0.72 | TDP1 (0.54) | NFKB1CYP2D6LMNAALDH1A1KMT2A | |
| SCHEMBL1908887 | 0.72 | LMNA (0.58) | NFKB1LMNAALDH1A1KMT2AMEN1 | |
| SCHEMBL22389094 | 0.72 | TSHR (0.32) | THRBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209023-A1 | PEPTIDE COMPOUND, APPLICATION THEREOF AND COMPOSITION CONTAINING SAME | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2024-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240209023-A1 | PEPTIDE COMPOUND, APPLICATION THEREOF AND COMPOSITION CONTAINING SAME | VIP, NGLY1, FURIN | NFKB1 2469/4885CYP2D6 1858/4885LMNA 2754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.